Study Evaluating Pantoprazole in Children With GERD

Completed · Phase 3

Conditions studied: Gastroesophageal Reflux

In brief

The purpose of this study is to characterize the PK profile, safety and tolerability of single and multiple doses of pantoprazole in children aged 1 through 11 years with endoscopically proven GERD.

Key facts

Study ID
NCT00141817
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
41
Starts
2005-08-01
Expected to finish
2007-11-01
Last updated by the study team
2011-12-28

Who can join

Age: 1 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.